Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSIW) Intangibles (2022 - 2024)

TriSalus Life Sciences' Intangibles history spans 3 years, with the latest figure at $1.1 million for Q2 2024.

  • For Q2 2024, Intangibles changed N/A year-over-year to $1.1 million; the TTM value through Jun 2024 reached $1.1 million, changed N/A, while the annual FY2023 figure was $1.1 million, 40.52% up from the prior year.
  • Intangibles reached $1.1 million in Q2 2024 per TLSIW's latest filing, roughly flat from $1.1 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $1.1 million in Q4 2023 to a low of $802000.0 in Q4 2022.
  • Average Intangibles over 3 years is $1.0 million, with a median of $1.1 million recorded in 2024.
  • The largest YoY upside for Intangibles was 40.52% in 2023 against a maximum downside of 40.52% in 2023.
  • A 3-year view of Intangibles shows it stood at $802000.0 in 2022, then skyrocketed by 40.52% to $1.1 million in 2023, then decreased by 1.24% to $1.1 million in 2024.
  • Per Business Quant, the three most recent readings for TLSIW's Intangibles are $1.1 million (Q2 2024), $1.1 million (Q1 2024), and $1.1 million (Q4 2023).